Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Celltrion will not face a PI from the Unified Patent Court against its biosimilar of Novartis' asthma drug Xolair. Today, Düsseldorf local division dismissed the PI application by Novartis and
Dec 18 - Amgen's (AMGN.O) leukemia drug Blincyto infringes patents owned by Germany's Lindis Biotech, a Delaware federal jury said in a verdict made public on Wednesday, awarding Lindis $50.3 million
's claim in the dispute over Targin. For years, Frankfurt-based Mundipharma defended market exclusivity for its painkiller Targin against various generic drug manufacturers. The product combines two
In the ongoing dispute over its highly successful weight-loss drug semaglutide, Novo Nordisk has suffered a further setback as the EPO revoked yet another patent from several under attack. After the
Context: Semaglutide (glp-1 receptor) is the active ingredient found in Ozempic, a Novo Nordisk drug used for the treatment of type 2 diabetes that generated global sales of approximately $13.9
Context: Entresto, a Novartis drug used to treat chronic heart failure, first approved in 2015, will be among the first high-spend drugs subject to government-negotiated pricing for Medicare patients
Generic drug companies cannot launch their enzalutamide products in the Netherlands. In the pan-European dispute over prostate cancer drug Xtandi, the District Court The Hague upheld a basic patent
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
